Market Overview:
The global single cell multi-omics market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for single cell analysis in various applications such as oncology, cell biology, neurology, immunology and others. Additionally, technological advancements in the field of single cell analysis are also propelling the growth of this market. North America dominates the global single cell multi-omics market followed by Europe and Asia Pacific region.
Product Definition:
A single cell multi-omics approach refers to the study of all molecular characteristics of a single cell. This approach is important because it allows for a more complete understanding of the cellular makeup and function. Additionally, single cell multi-omics can be used to detect rare cells within a population and track their changes over time.
Single Cell Genomics:
Single Cell Genomics (SCG) is the study of genetic material in a single cell. It helps in gaining information about the genotypic changes that have taken place in a cell and its response to external factors. Single-cell genome sequencing (SCGS) involves analyzing DNA content from numerous cells and extracting relevant data from them which can be further used for understanding various biological processes at molecular level.
Single Cell Proteomics:
Single Cell Proteomics (SCPP) is the study of proteomes, i.e., protein content, in single cells. It involves techniques such as mass spectrometry to analyze and measure different proteins in a cell at the same time as they are processed or made available for use by the cell.
Application Insights:
Oncology dominated the global single cell multi-omics market in terms of revenue share in 2017. This is due to an increase in cancer prevalence and number of new cancer cases diagnosed every year. According to the World Health Organization (WHO), around 1,633,480 new cases of cancer were diagnosed worldwide in 2018 and it is estimated that about 962,000 deaths due to cancer occurred last year. Single cell genomics has proven itself as a potential tool for oncology research with high accuracy and sensitivity which can be applied at various levels such as tumor profiling, molecular profiling or individualized medicine based on genomic analysis data.
Single cell proteomics also holds significant potential owing to its ability to identify biomarkers associated with different cancers such as lung, breast or colorectal carcinoma by analyzing protein expression patterns from single cells.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of key players, increased funding for omics research, and high adoption rate for advanced technologies in this region. Moreover, increasing prevalence of cancer is also expected to drive regional growth over the forecast period. For instance, according to data published by American Cancer Society in 2018’s annual edition about 1,735 new cases of lung cancer were reported among men and women in U.S., which indicates a significant increase compared with previous year’s statistics (1,639 cases).
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments from public & private entities as well as government agencies towards development of healthcare infrastructure coupled with growing awareness regarding early diagnosis and treatment options for various diseases including cancer & diabetes.
Growth Factors:
- Increasing demand for single cell analysis in various research applications such as cancer, immunology, and stem cells research is driving the growth of the global single cell multi-omics market.
- The increasing use of next-generation sequencing (NGS) technology for single cell analysis is another major factor propelling the growth of this market.
- The rising demand for personalized medicine is also fueling the growth of this market as single cell multi-omics helps in understanding the heterogeneity within a population of cells.
- Growing investments by leading players in R&D activities to develop novel technologies and products is also contributing to the growth of this market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Single Cell Multi-Omics Market Research Report
By Type
Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics
By Application
Oncology, Cell Biology, Neurology, Immunology, Others
By Companies
10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee, BGI Genomics, GE LifeSciences, Illumina, Takara Bio, QIAGEN N.V.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Single Cell Multi-Omics Market Report Segments:
The global Single Cell Multi-Omics market is segmented on the basis of:
Types
Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cell Biology, Neurology, Immunology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 10x Genomics
- 1CellBio
- MissionBio
- NanoString Technologies
- Fluidigm Corporation
- Fluxion Biosciences
- Bio-Rad Laboratories
- Celsee
- BGI Genomics
- GE LifeSciences
- Illumina
- Takara Bio
- QIAGEN N.V.
Highlights of The Single Cell Multi-Omics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Cell Genomics
- Single Cell Proteomics
- Single Cell Transcriptomics
- Single Cell Metabolomics
- By Application:
- Oncology
- Cell Biology
- Neurology
- Immunology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Single Cell Multi-Omics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Single Cell Multi-Omics is a research field that investigates how single cells interact with their environment to generate complex biological responses. This field is particularly important for understanding diseases and developing new treatments.
Some of the key players operating in the single cell multi-omics market are 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee, BGI Genomics, GE LifeSciences, Illumina, Takara Bio, QIAGEN N.V..
The single cell multi-omics market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Single Cell Multi-Omics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Single Cell Multi-Omics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Single Cell Multi-Omics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Single Cell Multi-Omics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Single Cell Multi-Omics Market Size & Forecast, 2018-2028 4.5.1 Single Cell Multi-Omics Market Size and Y-o-Y Growth 4.5.2 Single Cell Multi-Omics Market Absolute $ Opportunity
Chapter 5 Global Single Cell Multi-Omics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Single Cell Multi-Omics Market Size Forecast by Type
5.2.1 Single Cell Genomics
5.2.2 Single Cell Proteomics
5.2.3 Single Cell Transcriptomics
5.2.4 Single Cell Metabolomics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Single Cell Multi-Omics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Single Cell Multi-Omics Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Cell Biology
6.2.3 Neurology
6.2.4 Immunology
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Single Cell Multi-Omics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Single Cell Multi-Omics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Single Cell Multi-Omics Analysis and Forecast
9.1 Introduction
9.2 North America Single Cell Multi-Omics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Single Cell Multi-Omics Market Size Forecast by Type
9.6.1 Single Cell Genomics
9.6.2 Single Cell Proteomics
9.6.3 Single Cell Transcriptomics
9.6.4 Single Cell Metabolomics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Single Cell Multi-Omics Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Cell Biology
9.10.3 Neurology
9.10.4 Immunology
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Single Cell Multi-Omics Analysis and Forecast
10.1 Introduction
10.2 Europe Single Cell Multi-Omics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Single Cell Multi-Omics Market Size Forecast by Type
10.6.1 Single Cell Genomics
10.6.2 Single Cell Proteomics
10.6.3 Single Cell Transcriptomics
10.6.4 Single Cell Metabolomics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Single Cell Multi-Omics Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Cell Biology
10.10.3 Neurology
10.10.4 Immunology
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Single Cell Multi-Omics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Single Cell Multi-Omics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Single Cell Multi-Omics Market Size Forecast by Type
11.6.1 Single Cell Genomics
11.6.2 Single Cell Proteomics
11.6.3 Single Cell Transcriptomics
11.6.4 Single Cell Metabolomics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Single Cell Multi-Omics Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Cell Biology
11.10.3 Neurology
11.10.4 Immunology
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Single Cell Multi-Omics Analysis and Forecast
12.1 Introduction
12.2 Latin America Single Cell Multi-Omics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Single Cell Multi-Omics Market Size Forecast by Type
12.6.1 Single Cell Genomics
12.6.2 Single Cell Proteomics
12.6.3 Single Cell Transcriptomics
12.6.4 Single Cell Metabolomics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Single Cell Multi-Omics Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Cell Biology
12.10.3 Neurology
12.10.4 Immunology
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Single Cell Multi-Omics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Single Cell Multi-Omics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Single Cell Multi-Omics Market Size Forecast by Type
13.6.1 Single Cell Genomics
13.6.2 Single Cell Proteomics
13.6.3 Single Cell Transcriptomics
13.6.4 Single Cell Metabolomics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Single Cell Multi-Omics Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Cell Biology
13.10.3 Neurology
13.10.4 Immunology
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Single Cell Multi-Omics Market: Competitive Dashboard
14.2 Global Single Cell Multi-Omics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 10x Genomics
14.3.2 1CellBio
14.3.3 MissionBio
14.3.4 NanoString Technologies
14.3.5 Fluidigm Corporation
14.3.6 Fluxion Biosciences
14.3.7 Bio-Rad Laboratories
14.3.8 Celsee
14.3.9 BGI Genomics
14.3.10 GE LifeSciences
14.3.11 Illumina
14.3.12 Takara Bio
14.3.13 QIAGEN N.V.